CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Dec. 28, 2025	Dec. 29, 2024
Revenues:
Equipment and services	$ 10,466	$ 9,942
Licensing	1,786	1,727
Total revenues	12,252	11,669
Costs and expenses:
Cost of revenues	5,568	5,161
Research and development	2,453	2,230
Selling, general and administrative	865	723
Total costs and expenses	8,886	8,114
Operating income	3,366	3,555
Interest expense	(169)	(163)
Investment and other income, net	350	243
Income before income taxes	3,547	3,635
Income tax expense	(543)	(455)
Net income	$ 3,004	$ 3,180
Basic earnings per share	$ 2.81	$ 2.86
Diluted earnings per share	$ 2.78	$ 2.83
Shares used in per share calculations:
Basic	1,070	1,110
Diluted	1,079	1,122

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Dec. 28, 2025	Dec. 29, 2024
Operating Activities:
Net income	$ 3,004	$ 3,180
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	393	436
Income tax provision in excess of income tax payments	291	247
Share-based compensation expense	888	759
Net gains on marketable securities and other investments	(165)	(45)
Other items	(40)	(23)
Changes in assets and liabilities:
Accounts receivable, net	243	392
Inventories	(99)	111
Other assets	553	148
Trade accounts payable	(73)	11
Payroll, benefits and other liabilities	100	(541)
Unearned revenues	(130)	(88)
Net cash provided by operating activities	4,965	4,587
Investing Activities:
Capital expenditures	(549)	(277)
Purchases of debt and equity marketable securities	(883)	(914)
Proceeds from sales and maturities of debt and equity marketable securities	767	752
Acquisitions and other investments, net of cash acquired	(1,090)	(260)
Other items	34	28
Net cash used by investing activities	(1,721)	(671)
Financing Activities:
Proceeds from short-term debt	0	500
Repayment of short-term debt	0	(500)
Repurchases and retirements of common stock	(2,650)	(1,750)
Dividends paid	(949)	(942)
Payments of tax withholdings related to vesting of share-based awards	(280)	(315)
Other items	(3)	(1)
Net cash used by financing activities	(3,882)	(3,008)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0	(44)
Net (decrease) increase in total cash, cash equivalents and restricted cash	(638)	864
Total cash and cash equivalents at beginning of period (including $2,323 classified as restricted cash at September 28, 2025)	7,843	7,849
Total cash and cash equivalents at end of period	7,205	$ 8,713
Beginning Balance - Restricted Cash	2,323
Ending Balance - Restricted Cash	$ 0

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) shares in Millions, $ in Millions	Dec. 28, 2025	Sep. 28, 2025
Current assets:
Cash and cash equivalents	$ 7,205	$ 5,520
Restricted cash	0	2,323
Marketable securities	4,617	4,635
Accounts receivable, net	4,153	4,315
Inventories	6,665	6,526
Other current assets	1,968	2,435
Total current assets	24,608	25,754
Property, plant and equipment, net	4,893	4,690
Goodwill	14,183	11,358
Other intangible assets, net	1,627	1,148
Other assets	7,723	7,193
Total assets	53,034	50,143
Current liabilities:
Trade accounts payable	2,709	2,791
Payroll and other benefits related liabilities	1,505	1,839
Unearned revenues	379	358
Other current liabilities	5,229	4,156
Total current liabilities	9,822	9,144
Unearned revenues	79	71
Long-term debt	14,817	14,811
Other liabilities	5,243	4,911
Total liabilities	29,961	28,937
Commitments and contingencies (Note 5)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 8 shares authorized; none outstanding	$ 0	$ 0
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	8	8
Preferred stock, shares outstanding	0	0
Common stock and paid-in capital, $0.0001 par value; 6,000 shares authorized; 1,074 and 1,074 shares issued and outstanding, respectively	$ 0	$ 0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	6,000	6,000
Common stock, shares, issued	1,074	1,074
Common stock, shares, outstanding	1,074	1,074
Retained earnings	$ 22,498	$ 20,646
Accumulated other comprehensive income	575	560
Total stockholders’ equity	23,073	21,206
Total liabilities and stockholders’ equity	$ 53,034	$ 50,143